Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Marcocci C, Clarke BL, Abbott LG, Hofbauer LC, Kohlmeier L, Pihl S, An X, Eng WF, Smith AR, Ukena J, Sibley CT, Shu AD, Rejnmark L.
J Bone Miner Res. 2023 Jan;38(1):14-25. doi: 10.1002/jbmr.4726. Epub 2022 Nov 12.
[Secondary hypoparathyroidism].
Sato K.
Nihon Rinsho. 2006 Jun 28;Suppl 2:53-5.
Hypocalcemic cataract secondary to idiopathic hypoparathyroidism in an adolescent.
Zhang H, Yang L, Xie J, Zhao M, Liu X.
J Int Med Res. 2023 Aug;51(8):3000605231193820. doi: 10.1177/03000605231193820.
Fahr's syndrome, intracranial calcification and secondary hypoparathyroidism.
Chen JQ.
QJM. 2022 Jul 9;115(7):481-482. doi: 10.1093/qjmed/hcac078.
Hypoparathyroidism.
Breslau NA, Pak CY.
Metabolism. 1979 Dec;28(12):1261-76. doi: 10.1016/0026-0495(79)90141-0.
European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults.
Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM; European Society of Endocrinology.
Eur J Endocrinol. 2015 Aug;173(2):G1-20. doi: 10.1530/EJE-15-0628.
Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.
Donzuso G, Mostile G, Nicoletti A, Zappia M.
Neurol Sci. 2019 Nov;40(11):2251-2263. doi: 10.1007/s10072-019-03998-x. Epub 2019 Jul 2.
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.
Hannan FM, Kallay E, Chang W, Brandi ML, Thakker RV.
Nat Rev Endocrinol. 2018 Dec;15(1):33-51. doi: 10.1038/s41574-018-0115-0.
High incidence of chronic hypoparathyroidism secondary to total thyroidectomy.
Jørgensen CU, Homøe P, Dahl M, Hitz MF.
Dan Med J. 2020 May 1;67(5):A11190647.
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.
Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L, Hannan FM, Cetani F, Sikjær T, Formenti AM, Björnsdottir S, Schalin-Jantti C, Belaya Z, Gibb FW, Lapauw B, Amrein K, Wicke C, Grasemann C, Krebs M, Ryhänen EM, Makay O, Minisola S, Gaujoux S, Bertocchio JP, Hassan-Smith ZK, Linglart A, Winter EM, Kollmann M, Zmierczak HG, Tsourdi E, Pilz S, Siggelkow H, Gittoes NJ, Marcocci C, Kamenicky P; 2021 PARAT Working Group.
Eur J Endocrinol. 2022 Jan 13;186(2):R33-R63. doi: 10.1530/EJE-21-1044. Print 2022 Feb 1.
